Y-Intercept (Hong Kong) Ltd

Position in NVS — Novartis AG

CIK 1772875 HONG KONG, K3

Position in NVS

as of Jun 30, 2026 · filed Jul 14, 2026 Compact

Position Value

$1,093,592

-$5,999,507 QoQ

Shares Held

6,978

-85.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#593

of 1,603 holders

Holding Since

Jun 2021

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Y-Intercept (Hong Kong) Ltd holds $55,696,959 across 11 Drug Manufacturers - General names. NVS ranks #10 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	74,248	$18,683,766
2	LLY	ELI LILLY & Co	8,310	$9,967,264
3	GILD	Gilead Sciences, Inc.	57,007	$7,202,264
4	MRK	Merck & Co., Inc.	51,433	$6,609,140
5	NVO	Novo Nordisk A S	86,018	$4,123,702
6	BMY	Bristol Myers Squibb Co	46,615	$2,685,956
7	AMGN	Amgen Inc	5,281	$1,912,355
8	GSK	GSK plc	24,289	$1,273,229

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,093,592	6,978	-85.0%	Shares	Sole	2026-07-14
2026-03-31	$7,093,099	46,436	+73.7%	Shares	Sole	2026-04-27
2024-12-31	$2,601,193	26,731	+7.5%	Shares	Sole	2025-02-04
2024-03-31	$2,404,320	24,856	+28.2%	Shares	Sole	2024-05-10
2023-12-31	$1,958,111	19,393	+3.0%	Shares	Sole	2024-02-13
2022-09-30	$1,431,800	18,837	+294.5%	Shares	Sole	2023-02-14
2022-06-30	$403,630	4,775	-6.2%	Shares	Sole	2022-08-08
2022-03-31	$446,559	5,089	-30.0%	Shares	Sole	2022-05-16
2021-12-31	$636,081	7,272	-68.3%	Shares	Sole	2022-02-14
2021-09-30	$1,878,159	22,966	-1.3%	Shares	Sole	2021-11-15
2021-06-30	$2,123,702	23,276	—	Shares	Sole	2021-08-26
No filing history on record for this holder in this stock.